Is "pre-preclinical AD" helpful to the EU/US CTAD Task Force? - Sorbonne Université
Journal Articles The Journal of prevention of Alzheimer's disease Year : 2021

Is "pre-preclinical AD" helpful to the EU/US CTAD Task Force?

Timothy Daly
  • Function : Author
  • PersonId : 1119925
Sciences, Normes, Démocratie

Domains

Human health and pathology
Fichier principal
Vignette du fichier
Daly - 2021 - Is “Pre-Preclinical AD” Helpful to the EUUS CTAD .pdf (210.39 Ko) Télécharger le fichier
Origin Files produced by the author(s)

Gestionnaire HAL 3 Sorbonne Université  : Connect in order to contact the contributor

https://hal.sorbonne-universite.fr/hal-03474644

Submitted on : Friday, December 10, 2021-12:12:29 PM

Last modification on : Saturday, October 7, 2023-9:36:26 PM

Long-term archiving on : Friday, March 11, 2022-7:02:51 PM

Download

Dates and versions

hal-03474644 , version 1 (10-12-2021)

Identifiers

Cite

Timothy Daly. Is "pre-preclinical AD" helpful to the EU/US CTAD Task Force?. The Journal of prevention of Alzheimer's disease, 2021, pp.1-1. ⟨10.14283/jpad.2021.65⟩. ⟨hal-03474644⟩

Export

BibTeX XML-TEI Dublin Core DC Terms EndNote DataCite

Collections

CNRS SORBONNE-UNIVERSITE SU-LETTRES UMR-8011 SND
14 View
15 Download

Altmetric

Share

More